U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180421180421Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung CarcinomaRecruitingNo Results AvailableNon-Small Cell Lung Carcinoma|Venous ThromboembolismProcedure: Blood sample withdrawalhttps://ClinicalTrials.gov/show/NCT00192829
180422180422Pain Perception in Alzheimer's DiseaseRecruitingNo Results AvailableDementia Alzheimer TypeBehavioral: reaction to painhttps://ClinicalTrials.gov/show/NCT00192816
180423180423Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive DrugsNot yet recruitingNo Results AvailableNIDDMDrug: candesartanhttps://ClinicalTrials.gov/show/NCT00192803
180424180424Pain Perception is Attenuated in Patients With Painless Myocardial InfarctionCompletedNo Results AvailableMyocardial Infarction|Myocardial Ischemiahttps://ClinicalTrials.gov/show/NCT00192790
180425180425Concurrent Xeloda and Radiotherapy for Bone MetastasesRecruitingNo Results AvailableSolid Tumors|Bone MetastasesDrug: Xeloda|Procedure: External Beam Radiotherapyhttps://ClinicalTrials.gov/show/NCT00192777
180426180426High Dose CHOP in LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: high-dose cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00192764
180427180427From Compliance to Alliance: Engaging Psychiatric Patients in Illness ManagementRecruitingNo Results AvailablePatients Diagnosed With Severe Mental IllnessBehavioral: Psychoeducational group sessionshttps://ClinicalTrials.gov/show/NCT00192751
180428180428Does Telephone Follow-up Improve Patients SatisfactionCompletedNo Results AvailableCongestive Heart Failure|Angina Pectoris|Pneumonia|Urinary Tract Infectionhttps://ClinicalTrials.gov/show/NCT00192738
180429180429Tryptophan Depletion in Acute ManiaCompletedNo Results AvailableBipolar DisorderOther: rapid tryptophan depletionhttps://ClinicalTrials.gov/show/NCT00192725
180430180430Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: irinotecan, gemcitabinehttps://ClinicalTrials.gov/show/NCT00192712
180431180431Bimetric-10: Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric StemCompletedNo Results AvailableOsteoarthrosisDevice: Bimetric femoral stemhttps://ClinicalTrials.gov/show/NCT00192699
180432180432Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKACompletedNo Results AvailableTotal Knee Arthritis|Viral; Infection, Slow VirusProcedure: culture a.m. Kamme-Lindberghttps://ClinicalTrials.gov/show/NCT00192686
180433180433Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment CoursesRecruitingNo Results AvailableAcute Lymphoblastic LeukemiaDrug: PEG-asparaginasehttps://ClinicalTrials.gov/show/NCT00192673
180434180434HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)CompletedNo Results AvailableHIV-Associated Lipodystrophy Syndrome|Cardiovascular DiseaseDrug: Lamivudine|Drug: Stavudine|Drug: Didanosine|Drug: Zidovudine|Drug: Tenofovir|Drug: Abacavir|Drug: Efavirenz (EFV)|Drug: Nevirapine|Drug: Indinavir|Drug: Saquinavir|Drug: Amprenavir|Drug: Ritonavir|Drug: Nelfinavir|Drug: Tipranavir|Drug: enfuvirtide (T20)https://ClinicalTrials.gov/show/NCT00192660
180435180435Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1CompletedNo Results AvailableChronic Hepatitis CDrug: high dose peg-ifn plus rbv|Drug: standard peg-ifn plus ribavirinhttps://ClinicalTrials.gov/show/NCT00192647
180436180436A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL StudyCompletedNo Results AvailableHIV InfectionsDrug: Emtricitabine 200mg - Tenofovir 300mg|Drug: Abacavir 600mg - Lamivudine 300mghttps://ClinicalTrials.gov/show/NCT00192634
180437180437Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsCompletedNo Results AvailableHIV Infections|Dyslipidemias|Glucose Metabolism Disorders|Metabolic Diseases|Lipodystrophy|Cardiovascular DiseaseDrug: Combivir (zidovudine [AZT] / lamivudine [3TC])|Drug: Kaletra (lopinavir [LPVr])https://ClinicalTrials.gov/show/NCT00192621
180438180438A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 StudyCompletedNo Results AvailableHIV InfectionsDrug: saquinavir 500 formulation|Drug: cross-over armhttps://ClinicalTrials.gov/show/NCT00192608
180439180439Tenofovir in HIV/HBV CoinfectionCompletedNo Results AvailableHIV Infection|Hepatitis B CoinfectionDrug: Tenofovir|Drug: Zidovudine (AZT), lamivudine (LAM), efavirenz (EFV)https://ClinicalTrials.gov/show/NCT00192595
180440180440AIMHI NT Relapse Prevention TrialActive, not recruitingNo Results AvailableSchizophrenia|Schizoaffective Disorder|Psychoses, Substance Induced|Depression|Bipolar DisorderBehavioral: Motivational Interview with care plan and educationhttps://ClinicalTrials.gov/show/NCT00192582
180441180441Australian Trial in Acute Hepatitis CCompletedNo Results AvailableHepatitis CDrug: Pegylated Interferon alfa 2a|Drug: Ribavirin (HIV conifected patients only)https://ClinicalTrials.gov/show/NCT00192569
180442180442Food Incentives for TB Treatment Compliance in East Timor (FITTCET)CompletedNo Results AvailableTuberculosisBehavioral: foodhttps://ClinicalTrials.gov/show/NCT00192556
180443180443The Fish and Fruit Study: Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal DiseaseCompletedNo Results AvailableCardiovascular DiseasesBehavioral: diet of fish and fruit|Behavioral: fruit and fish|Behavioral: diet only|Behavioral: regular diethttps://ClinicalTrials.gov/show/NCT00192543
180444180444Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque PsoriasisCompletedNo Results AvailablePsoriasisDrug: MEDI-522|Other: Placebohttps://ClinicalTrials.gov/show/NCT00192517
180445180445A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized CompletedNo Results AvailableRespiratory Syncytial Virus InfectionsBiological: MEDI-524https://ClinicalTrials.gov/show/NCT00192504
180446180446Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNo Results AvailableInfluenzaBiological: FluMist|Biological: FluMist|Other: Placebohttps://ClinicalTrials.gov/show/NCT00192491
180447180447Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524CompletedNo Results AvailableRespiratory Syncytial Virus InfectionsBiological: Medi-524https://ClinicalTrials.gov/show/NCT00192478
180448180448Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy AdultsCompletedNo Results AvailableRespiratory Syncytial Virus InfectionsBiological: MEDI-524 (Numax-TM)|Biological: MEDI-524 (Numax-TM)|Biological: MEDI-524 (Numax-TM)|Biological: MEDI-524 (Numax-TM)|Biological: MEDI-524 (Numax-TM)https://ClinicalTrials.gov/show/NCT00192465
180449180449Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque PsoriasisCompletedNo Results AvailablePsoriasisDrug: MEDI-507https://ClinicalTrials.gov/show/NCT00192452
180450180450Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High RiskCompletedNo Results AvailableSevere Respiratory DiseaseBehavioral: High Risk Respiratory Diseasehttps://ClinicalTrials.gov/show/NCT00192439

* Görseller ve İçerik tekif hakkına sahip olabilir